1.BackgroundPMOP is linked to an imbalanced bone microenvironment and chronic inflammation, with rapid deterioration of bone microstructure. Current osteogenic molecules
BackgroundHydrogen demand is driving electrolytic water splitting, and Pt remains highly efficient for alkaline hydrogen evolution but costly. MXene is
BackgroundEGFR-mutant NSCLC brain metastasis with acquired TKI resistance remains a hard niche. Resistant cells show redox perturbation: elevated ROS, weakened
Bone Defects BackgroundAs populations age, osteoporotic bone defects often coexist with bacterial infection. Drug-resistant bacteria and intracellular escape make conventional
Fracture healing Research Background: Clinical observations indicate anxiety can interfere with post‑fracture repair, yet the underlying immunological regulatory logic remains
Research Background: （Hydrogels） Periodontal‑related lesions can trigger alveolar bone loss. Conventional approaches mostly only target pathogenic bacteria, ignoring toxin clearance
Research Background: Human tissues feature unique strain‑stiffening behaviors. They stay soft under small deformation and rapidly stiffen under large load.
BackgroundHigh-glucose wound beds often face a tangled mix of infection, lingering inflammation, poor oxygen supply, and weak vessel growth. ROS